Patients with metastatic castration-sensitive prostate cancer (mCSPC), who have specific genetic mutations, were found to ...

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

Former President Joe Biden’s metastatic cancer diagnosis brings together two controversial issues: PSA testing for prostate ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to the Oral Abstract Session: Genitourinary Cancer—Prostate, Testicular, and Penile.

Adding CAN-2409 to standard radiation therapy significantly improved disease-free survival and pathological complete response ...

Q. Turmeric and rosemary are two ingredients among ten in an over-the-counter supplement I take. In lab studies, the ...

Men’s Health Month 2025 encourages men to adopt preventive care and healthy lifestyle habits to improve overall health ...

From Real Housewives to Real Talk About Prostate Cancer. Okay ladies, gather around. We need to talk about something a little ...

Eric Morrow told his doctor about his family history of prostate cancer and asked if he needed testing. His doctor said no.

At a median follow-up of 60.7 months, patients in the combination arm of enzalutamide + leuprolide had significantly superior 5-year metastasis free survival rates (87.3% versus 71.4%; HR: 0.42, 95% ...

Patients with a detectable PSA level will remain on treatment until progression on PSMA PET-CT. Patients are considered eligible for the study if they have histologically or cytologically confirmed ...